Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 11/20 | 0.47 |
| ▸ | CES1 | P23141 | 10/20 | 0.47 |
| ▸ | CES2 | O00748 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL474408 | 1.00 | FAAH (0.47) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL313800 | 0.89 | FAAH (0.38) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL7219610 | 0.89 | FAAH (0.38) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL5533296 | 0.83 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL540827 | 0.83 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| Hydrochloric Acid SCHEMBL2556207 | 0.82 | FAAH (0.53) | FAAHCES1CES2MEN1CYP1A2 | |
| Hydrochloric Acid SCHEMBL28875 | 0.82 | FAAH (0.53) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL28766942 | 0.79 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL27899377 | 0.77 | FAAH (0.48) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL4753504 | 0.77 | FAAH (0.44) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2361605-B2 | Use of linear volatile alkane(s), solid fatty alcohol(s) and sugar-based polymeric thickener(s) for the cosmetic treatment of keratin fibres | OREAL (FR) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023141803-A1 | COMPOSITION SUITABLE FOR HIGH CONTENT OF OIL | L'OREAL (FR) | 2023-08-03 | — | — | WO | disclosed |
| WO-2022178849-A1 | IRRITATION REDUCED SURFACTANT COMPOSITION | L'OREAL (FR) | 2022-09-01 | — | — | WO | disclosed |
| WO-2022178848-A1 | COMPOSITION FOR IMPROVING SURFACTANT | L'OREAL (FR) | 2022-09-01 | — | — | WO | disclosed |
| WO-2021134458-A1 | COMPOSITION FOR CONDITIONING KERATIN MATERIALS | L'OREAL (FR) | 2021-07-08 | — | — | WO | disclosed |
| WO-2021134463-A1 | COMPOSITION FOR CONDITIONING KERATIN MATERIALS | L'OREAL (FR) | 2021-07-08 | — | — | WO | disclosed |
| EP-2552596-B1 | AIRBRUSH | OREAL (FR) | 2018-09-05 | — | — | EP | disclosed |
| EP-2361605-B1 | Use of linear volatile alkane(s), solid fatty alcohol(s) and sugar-based polymeric thickener(s) for the cosmetic treatment of keratin fibres | L'ORÉAL (FR) | 2018-01-24 | — | — | EP | disclosed |
| US-9827178-B2 | Composition containing a volatile linear alkane, an aminated silicone and a vegetable oil | L'OREAL (FR) | 2017-11-28 | — | — | US | disclosed |
| EP-2338466-B1 | Cosmetic composition containing at least one volatile linear alkane, at least one amine silicone having a particular content, and at least one vegetable oil | L'ORÉAL (FR) | 2017-03-08 | — | — | EP | disclosed |
| EP-2338468-A1 | Cosmetic composition comprising at least one volatile linear alkane, at least one cationic surfactant whereby the two components are in a specific ratio | L'Oréal (FR) | 2011-06-29 | — | — | EP | disclosed |
| EP-2338467-A1 | Cosmetic composition including at least one volatile linear alkane, at least one silicone and at least one glyceride with a specific ratio of glyceride to silicone | L'Oréal (FR) | 2011-06-29 | — | — | EP | disclosed |
| US-20110150786-A1 | COMPOSITION CONTAINING A VOLATILE LINEAR ALKANE, AN AMINATED SILICONE AND A VEGETABLE OIL | L'OREAL (FR) | 2011-06-23 | — | — | US | disclosed |
| US-7470651-B2 | Clear conditioning compositions comprising coacervate | THE PROCTER & GAMBLE COMPANY (US) | 2008-12-30 | — | — | US | disclosed |
| EP-1893298-A1 | CONDITIONING COMPOSITIONS COMPRISING COACERVATE AND CONDITIONING AGENT | The Procter and Gamble Company (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-1893299-A1 | CLEAR CONDITIONING COMPOSITIONS COMPRISING A COACERVATE | The Procter and Gamble Company (US) | 2008-03-05 | — | — | EP | disclosed |
| WO-2007002565-A1 | CLEAR CONDITIONING COMPOSITIONS COMPRISING A COACERVATE | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| WO-2007002564-A1 | CONDITIONING COMPOSITIONS COMPRISING COACERVATE AND CONDITIONING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20060293197-A1 | Conditioning compositions comprising coacervate and conditioning agent | THE PROCTER & GAMBLE COMPANY | 2006-12-28 | — | — | US | disclosed |
| US-20060293213-A1 | Clear conditioning compositions comprising coacervate | THE PROCTER & GAMBLE COMPANY | 2006-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110150786-A1 | COMPOSITION CONTAINING A VOLATILE LINEAR ALKANE, AN AMINATED SILICONE AND A VEGETABLE OIL | KRT18, VIM, ALK | FAAH 457/4885CES1 4078/4885CES2 3132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.